Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2005
03/03/2005US20050049183 Using tamm-Horsefall glycoprotein to treat asthma, allergies, chronic inflammatory bowel disorders, viral infection, multiple sclerosis and migraines
03/03/2005US20050049182 Therapeutic formulation comprising cationic peptide, viscosity-increasing agent, and solvent, wherein the cationic peptide contains up to 35 amino acids; use in treating or preventing infectious disease associated with foreign bodies, primary or seconary infection sites
03/03/2005US20050049180 VGF polypeptides and methods of treating VGF-related disorders
03/03/2005US20050049179 For analyzing and prescribing changes to daily insulin-dosing schedule of diabetic patients using insulin pumps, multiple-dose injection, or inhaled insulin; divides day into selected time intervals in which adjustable schedules are provided for Basal Insulin dosage rates, Carbohydrate-to-insulin ratios
03/03/2005US20050049177 Proteolysis-resistant peptide hormones; peptide or polypeptide analogs that are resistant to cleavage by proteinases; use as therapeutic agents and in diagnosis
03/03/2005US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease
03/03/2005US20050049175 Use of neurotoxin therapy for treatment of urologic and related disorders related to urinary retention
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048632 Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
03/03/2005US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast
03/03/2005US20050048627 Tissue inhibitors of metalloproteinases (TIMP) for use in treatment and prevention of cell proliferative disorders; antitumor agents
03/03/2005US20050048626 BAFF variants and methods thereof
03/03/2005US20050048625 Mammalian cytokines; related reagents and methods
03/03/2005US20050048623 Cell cycle and proliferation proteins
03/03/2005US20050048622 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders
03/03/2005US20050048618 Zsig33-like peptides and polynucleotides
03/03/2005US20050048614 Biosynthetic oncolytic molecules and uses therefor
03/03/2005US20050048613 Expression vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of lung and or colon tumors; antitumor agents
03/03/2005US20050048610 Human transport proteins
03/03/2005US20050048607 Using activin receptor like kinases (ALK) as tool in identifying modulators for disganosis, prevention and treatment of cancer, rheumatoid arthritis and glomerulonephritis
03/03/2005US20050048605 Novel polypeptide dna thereof and use of the same
03/03/2005US20050048603 Expression of membrane proteins using an adenylyl cyclase of mycobacterium tube rculosis
03/03/2005US20050048602 Kidney repairing factor
03/03/2005US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy
03/03/2005US20050048588 Mimetic amino acid sequences for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy; genetic vaccines
03/03/2005US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof
03/03/2005US20050048560 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
03/03/2005US20050048559 Compositions and methods relating to breast specific genes and proteins
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048552 Higher order structure and binding of peptide nucleic acids
03/03/2005US20050048550 Ephrin-A2 lymphocyte receptor modulator for use in treatment and prevention of renal cell carcinoma; mimetics and antitumor agents
03/03/2005US20050048538 Hypocretin receptor in regulation of sleep and treatment of sleep disorders
03/03/2005US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same
03/03/2005US20050048529 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
03/03/2005US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay
03/03/2005US20050048520 Nogo receptor homologs
03/03/2005US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening
03/03/2005US20050048507 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/03/2005US20050048479 Adenylyl and guanylyl cyclases
03/03/2005US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
03/03/2005US20050048471 Albumin derivatives with therapeutic functions
03/03/2005US20050048467 Method and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
03/03/2005US20050048133 Methods for treating ischemic disorders using carbon monoxide
03/03/2005US20050048125 Glycoprotein matrix compositions and methods related thereto
03/03/2005US20050048120 Sustained release; interior lipophilic membrane; hydrophilic exterior membrane containing peptide
03/03/2005US20050048111 Atopic dermatitis treatment method
03/03/2005US20050048105 Forming skin barrier; polymer mixture containing protease inhibitor
03/03/2005US20050048087 Mixture of fatty ester, lipophilic excipient and nonionic surfactant as solubilizer for drugs such as cyclosporin a and cyclosporin g; bioavailability
03/03/2005US20050048084 Therapy for bladder infections
03/03/2005US20050048079 Induction response in cells; joining to adenosine triphosphate binding domain; therapy for Aids; anticancer agents
03/03/2005US20050048078 Protein polymer having unfold activity on higher-order structure of protein
03/03/2005US20050048070 Mixture of polypeptides from cytokeratins; anticancer agnets; vaccines
03/03/2005US20050048069 Methods and compositions for modulating immunity
03/03/2005US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response
03/03/2005US20050048067 Antiproliferative agents; therapy for autoimmune disease
03/03/2005US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit
03/03/2005US20050048062 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
03/03/2005US20050048061 Uses of mammalian cytokines and agonists; related reagents
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048049 A humanized antibody that binds to soluble A beta; may be monoclonal, polyclonal, single chain or fused to a heterologous polypeptide
03/03/2005US20050048047 Intrathecal administering of genetic engineered enzyme such as iduronidase; reduced storage of mucopolysaccharides
03/03/2005US20050048046 Administering topical or by injection; regenerating strength, thickness of aging skins
03/03/2005US20050048045 Regulation of urokinase receptor expression by phosphoglycerate kinase
03/03/2005US20050048044 Controlling, adjustment diffusion or degradation of membrane using activating energy source such as light source or ultraviolet radiation
03/03/2005US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells
03/03/2005US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050048028 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
03/03/2005US20050048027 Non-neurotoxic plasminogen activating factors for treating stroke
03/03/2005US20050048026 Remedies for ischemic diseases
03/03/2005US20050047999 Matrix metalloproteinase inhibitors
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005DE10335584A1 Verfahren zur Herstellung zyklischer Moleküle A process for preparing cyclic molecules
03/03/2005CA2536946A1 Estrogen receptor modulators and uses thereof
03/03/2005CA2536918A1 Serine protease inhibitors for treatment of bacterial infections
03/03/2005CA2536654A1 Anti-cancer vaccines
03/03/2005CA2536643A1 Interferon-.beta. complex
03/03/2005CA2536635A1 Novel fungal proteins and nucleic acids encoding same
03/03/2005CA2536152A1 G-csf derivative for inducing immunological tolerance
03/03/2005CA2536112A1 Methods for enhancing embryo viability
03/03/2005CA2536071A1 Methods for detecting regulatory effect on synoviolin activity
03/03/2005CA2535971A1 Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
03/03/2005CA2535807A1 Peptides with the capacity to bind to transforming growth factor .beta.1 (tgf-.beta.1)
03/03/2005CA2535799A1 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
03/03/2005CA2535754A1 Human autism susceptibility gene and uses thereof
03/03/2005CA2535745A1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005CA2535583A1 Method of inducing immune tolerance
03/03/2005CA2535581A1 Use of polypeptides of the cupredoxin family in cancer therapy
03/03/2005CA2535562A1 Improved method of purifying tfpi and tfpi analogs
03/03/2005CA2535513A1 Crosslinking within coordination complexes
03/03/2005CA2535343A1 Sprayable wound debrider
03/03/2005CA2535185A1 2-methylene-19-nor-vitamin d2 compounds
03/03/2005CA2532340A1 Separation of polypeptides comprising a racemized amino acid
03/03/2005CA2531146A1 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
03/03/2005CA2528292A1 A method for treating cancer patients undergoing chemotherapy
03/03/2005CA2526431A1 Compositions and methods for treatment of severe acute respiratory syndrome (sars)
03/03/2005CA2501155A1 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals
1 ... 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 ... 3163